Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 67,594 shares at $80.14 ($5.4M) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Scheduled sale ($5.4M) by CHIEF TECHNICAL Operations OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.14 | 1,650 | $132K | 2.4% |
| 2 | $80.14 | 1,900 | $152K | 2.8% |
| 3 | $80.15 | 4,715 | $378K | 7.0% |
| 4 | $80.15 | 4,715 | $378K | 7.0% |
| 5 | $80.17 | 6,101 | $489K | 9.0% |
| 6 | $80.17 | 6,101 |
| $489K |
| 9.0% |
| 7 | $80.19 | 21,206 | $1.7M | 31.4% |
| 8 | $80.19 | 21,206 | $1.7M | 31.4% |
| Total | $80.18 avg | 67,594 | $5.4M | 100% |
| Filing → |
| PTCT | SELL | 2026-06-30 | $693K | — | Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |